CFO4Life Group’s Aemetis AMTX Stock Holding History

CFO4Life Group’s Portfolio AMTX Stock Details AMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,460	Closed	-$135K	–	173
2023 Q2	$135K	Buy	+18,460	New	+$70.1K	0.03%	167

Other funds holding AMTX

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

ECA

Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

CFO4Life Group's AMTX Position: Q3 2023 in Review

CFO4Life Group sold out of Aemetis (AMTX) in Q3 2023, closing a stake of 18,460 shares — an estimated $135K sold.

CFO4Life Group first reported a position in AMTX in Q2 2023 and held it in 1 quarter. The position peaked at $135K in Q2 2023. 72 funds tracked by Wall St. Rank hold AMTX as of Q3 2023.

CFO4Life Group reported no remaining Aemetis position as of Q3 2023 after selling out during the quarter.
CFO4Life Group sold 18,460 Aemetis shares in Q3 2023, an estimated $135K.
CFO4Life Group first reported a position in Aemetis in Q2 2023 and held it in 1 quarter.
CFO4Life Group's Aemetis position peaked at $135K in Q2 2023.
72 funds tracked by Wall St. Rank held Aemetis as of Q3 2023.

Based on CFO4Life Group's 13F filing for Q3 2023, filed 30 Oct 2023.